<?php $root = $_SERVER["DOCUMENT_ROOT"];?>
<?php require $root.'/global/html/header.html';?>
<?php require $root.'/global/html/menu.html';?>

<section style="background:url(img/background.png);background-size:100% 100%;" id="slide_container">
    <h1>Potential Spotlight cost savings<sup>1</sup></h1>           

<h2>Nasofan<sup>®</sup>
costs approximately 27% less than
Flixonase<sup>®</sup>
(fluticasone aqueous 50 mcg nasal spray), or
prescribing fluticasone aqueous 50 mcg nasal spray
generically,* which could deliver costs savings of up
to £2.97 (150 dose presentation) per prescription. At a
Primary Care </h2><h2>Organisation (PCO) level, this translates
into a potential average annual saving of over
£14,532<sup>1</sup></h2>



 <img class="fullscreen" src="img/cost_savings_one.png" alt="" />                               
    
    <div id="notes">

        <p>*This will be reimbursed at the Cat C price in the Drug
                                Tariff in England and Wales. Fluticasone aqueous 50 mcg
                                nasal spray is not available generically in NHS
                                Scotland</p>

        <p>An average PCO represents a population of approximately
                                272,000 people. Please note: the term Primary Care
                                Organisation refers to Clinical Commissioning Groups
                                (England), NHS Boards (Scotland), Local Health Boards
                                (Wales) and Health and Social Care Trusts (Northern
                                Ireland)</p>

  
    </div>

       <p class="side_note">Date of preparation: July 2014  UK/SPL/14/0017k</p>
</section>


<?php require $root.'/global/html/footer.html';?>